The Federal Circuit has reinstated parts of a Rhode Island jury’s verdict, which found that an Italian company’s blood analyzer computer code was stolen by a U.S. rival. This decision comes as another jury will be tasked with determining any potential damages. This complex case highlights ongoing issues in the competitive landscape of medical technology and intellectual property. For further details, including the court’s full analysis and implications for future cases, read the original article.